Georgia State University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Georgia State University sits in the top decile of US sponsors by registered trial count (#397 of 15,742 sponsors by registered trial count).
Georgia State University: 45 sponsored US clinical trials, 15 recruiting.
Georgia State University sponsors 45 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 26 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Endothelial Function (Reactive Hyperemia), with 3 trials.
Top-decile sponsor footprint
Georgia State University ranks in the top decile of sponsors by registered trial count (#397 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
26 of 27 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
45 total, page 1 of 1
Peer Influences in Alcohol and Sexual Violence Among Marines Dyads
NCT07256275
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
NCT06919900
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
NCT06629428
Communicating About Nicotine Reduction in Cigarettes
NCT06787937
Clinical and Biochemical Effects of a Defined Plant-Based Diet on Heart Disease
NCT06994624
Peanuts for Cardiometabolic, Brain, and Intestinal Health
NCT06867198
Effect of a Humanoid Robot With Virtual Reality Games to Train Arm Function in Children With Cerebral Palsy - THRIVE Trial
NCT06881407
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
NCT06735651
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
NCT06735599
Timing and Facilitation Effects of Theta-Burst Stimulation in the Reading and Language Networks
NCT06608680
Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)
NCT05205980
Biphasic Effects of Acute Alcohol Intoxication on Bystander Intervention
NCT05701865
Just-In-Time Intervention to Reduce Alcohol-Facilitated Intimate Partner Violence Perpetration
NCT05145868
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
NCT05000632
Effects of Treadmill Training and Whole-body Vibration in Children With Cerebral Palsy
NCT04630392
Calling All Dads! Evaluation of APAs ACT Program: Engaging Fathers to Prevent Adverse Childhood Experiences
NCT06075446
Effects of Ocrevus in Relapsing Multiple Sclerosis
NCT04387734
A Mindfulness-based Intervention for Sexual Assault Survivors
NCT07515586
Testing Different Anti-smoking Messages Among Chinese Young Adult Smokers and Nonsmokers
NCT06730646
Impact of Non-invasive Brain Stimulation on Learning Novel Spoken Words
NCT06387615
Improving Care Through Improv: Promoting Mastery in the Moment
NCT05996718
Testing the Efficacy of a Brief Alcohol Intervention Among College Students
NCT06776796
Messages About Reduced Nicotine in Combusted Tobacco Products
NCT05506046
Treadmill Training in People With Parkinson's Disease
NCT05239026
Promoting Prosocial Bystander Behavior in Intoxicated Men: Evaluation of RealConsent2.0
NCT04912492
Role of Early Motor Experience in Infants With Down Syndrome
NCT05144373
Action Observation as a Rehabilitation Intervention for Stroke
NCT05001958
Technology-Based Prevention for Adolescents in Primary Care
NCT03489434
Mindfulness-based Smoking Cessation Enhanced With Mobile Technology
NCT04965181
Proximal Effects of Alcohol on Same-Sex Intimate Partner Violence
NCT04625465
Effects of TBS on Reading in Adult Struggling Readers
NCT04041960
Trauma-Informed Mindfulness-Based Yoga
NCT03581461
Efficacy of a Web-based Sexual Violence Risk Reduction Program for Female College Students
NCT03726437
Alcohol and Violence Prevention for College Students
NCT04089137
Reducing Maternal Depression and Promoting Infant Social-Emotional Health & Development
NCT03464630
A Study Investigating The Effects Of An Ankle Rehabilitation Program On High School Athletes With Ankle Instability
NCT03447652
Stroke COunseling for Risk REduction
NCT03076125
iQuit Mindfully: Text Messaging for Smoking Cessation
NCT03029819
Vibration Training for Preventing Falls in Healthy Population and Multiple Sclerosis
NCT02694666
Development of the DRIVE Curriculum to Address Childhood Obesity Risk Factors
NCT02160847
A Technology-Enhanced Approach for Implementing Evidence-Based Practices in Child Welfare
NCT02430337
Maternal HIV: Trial to Assist Disclosure to Children
NCT01922206
Effectiveness and Cost-effectiveness of Coaching Models to Promote Implementation of an Evidence-based Parenting Program
NCT01791777
Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief
NCT00919100
Virtual Reality Exposure Therapy for the Treatment of Social Phobia
NCT02379949
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
What is open in the Georgia State University pipeline
15 recruiting of 45 indexed (33% open); 26 completed (58%).
Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).
Top condition: Endothelial Function (Reactive Hyperemia) (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Georgia State University: open-pipeline peers nationwide
Peers matched on 45 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Georgia State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 45 trials (± recruiting share)
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · 45 trials · 4% recruiting
- AIDS Malignancy Consortium · 45 trials · 11% recruiting
- Cambridge Health Alliance · 45 trials · 16% recruiting
- Carilion Clinic · 45 trials · 20% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Georgia State University page
45 registered trials is a research-attention snapshot, not an endorsement of Georgia State University or any single study.
- 15 of Georgia State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Endothelial Function (Reactive Hyperemia) is the condition Georgia State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Endothelial Function (Reactive Hyperemia) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Georgia State University pipeline card: 45 registered trials from official public datasets.Report a data error.